4:54 pm Chelsea Therapeutics confirms FDA accelerated approval of NORTHERA (droxidopa) for the treatment of symptomatic NOH (stock halted)
View todays social media effects on CHTP
View the latest stocks trending across Twitter. Click to view dashboard
See who Chelsea is hiring next, click here to view
